Emergence is supported by a network of world-leading experts in immuno-oncology and leading international investors. Kurma Partners led the Company’s seed funding round and acted as the originator and incubator investor. Pontifax Venture Capital led the subsequent series A funding round. Further investors and partners include RA Capital Management, OrbiMed Advisors, Surveyor Capital (a Citadel company) Hadean Ventures, Bpifrance, Gründerfonds Ruhr, Heidelberg Pharma Research GmbH, High-Tech Gründerfonds, Eurazeo and NRW.BANK.

ETX Investors
& Partners


Pontifax Venture Capital

Bpi France

Gründerfonds Ruhr

Hadean Ventures

Heidelberg Pharma

High-Tech Gründerfonds



Orbimed Advisors

RA Capital Management

Surveyor Capital (a Citadel Company)